Publications
Shield and our collaborators actively publish and present new data. Please find key publications and posters below.
2020 | Nephrology Dialysis Transplantation
Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease.
Mark Sampson, Nuno Faria, Jonathan J. Powell
Read More2020 | European Respiratory Journal
Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
Karen M Olsson, Jan Fuge, Torben Brod, Jan C Kamp, Jan Schmitto, Tibor Kempf, Johann Bauersachs, Marius M Hoeper
Read More2020 | Journal of Clinical Medicine
Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic
Ferdinando D’Amico, Laurent Peyrin-Biroulet and Silvio Danese
Read More2020 | 15th Congress of ECCO 2020
Impact of oral ferric maltol and IV iron on health-related quality of life in patients with iron deficiency anaemia and inflammatory bowel disease, and relationship with haemoglobin and serum iron
Stefanie Howaldt, Ian Jacob, Mark Sampson, Fatma Akriche
Read More2020 | 15th Congress of ECCO 2020
Health care resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease
Stefanie Howaldt, Ian Jacob, Mark Sampson, Fatma Akriche
Read More2020 | 15th Congress of ECCO 2020
Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: a comparison of ferric maltol and IV iron
Stefanie Howaldt, Ian Jacob, Mark Sampson, Fatma Akriche
Read More